With this first issue of 2021, you may notice something different on the cover and on the banner of our website. This special design features a teal ribbon wrap and related content for cervical cancer content.
As women’s health care providers, you likely know that January is Cervical Cancer Awareness month. The teal ribbon is its awareness symbol. To complement the print issue, key elements on our website will turn teal for the entire month of January and we will have related articles and interviews on the topic of cervical cancer. This is a first for us and we would like to hear your feedback on it.
Under the astute guidance of Editor-in-Chief Catherine Y. Spong, MD, we also are launching a new feature in this issue called Curbside Consults that engages practitioners outside of ob/gyn with expertise in health issues that may affect pregnant women. Take a dive into dental issues in pregnancy with 'Dental dilemmas in pregnancy.'
The other features in this issue focus on obstetrics, from the cover story on one method to address recurrent pregnancy loss by Nisse Clark, MD, MPH, to the article on diagnosis and management of syphilis in pregnancy by Emily Adhikari, MD, who reminds us that there are other infectious pathogens affecting our patients as we all work to get to the end of the COVID-19 pandemic.
We encourage your feedback. Please connect with us at COGeditorial@mmhgroup.com. Best wishes for a safe, healthy, and happy new year.
__
Mike Hennessy Sr.
Chairman and Founder, MJH Life Sciences
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More